Αποτελέσματα Αναζήτησης
The graduate studies programme of the School has been in operation since the academic year 2001-2002, offering specialization in various areas of pharmacy and leading to MSc in Pharmacy (five specializations) and PhD degrees. The five specializations include: Medicinal Chemistry, Development of Pharmaceutical Compounds.
- Personnel
Personnel - School of Pharmacy
- Studies
Studies - School of Pharmacy
- Useful Links
Useful Links - School of Pharmacy
- School/Administration
School/Administration - School of Pharmacy
- Assembly
Assembly - School of Pharmacy
- Secretariat
Secretariat - School of Pharmacy
- Personnel
Professor Sir Alimuddin Zumla is professor of infectious diseases and international health at University College London. He is also a consultant infectious diseases at UCLH, honorary consultant at Royal Free Hospital, and holds a UK NIHR senior Investigator award.
Aristotle University of Thessaloniki School of Pharmacy University Campus, 54124 Thessaloniki, Greece Τ: +302310997633 +302310997623 +302310997613 +302310998880 E: info@pharm.auth.gr
The UCL School of Pharmacy is one of the most highly-rated pharmacy schools in the UK. As the oldest school, founded by the Pharmaceutical Society of Great Britain in 1842, it has over 180 years of experience and tradition throughout which it has retained its identity as a specialist institution dedicated to teaching and research in pharmacy ...
Prof Sir. Ali Zumla. TEACHING INTERESTS. 1. CHAMPIONING GLOBAL HEALTH TEACHING & CURRICULUM DEVELOPMENT: Pioneered, championed and made visible 'Global Health' at UCL since 1994 as Director of the UCL Centre for Infectious Diseases & International Health.
Scientific subjects. The research interests of the Department of Pharmaceutical Chemistry are focused on many targets. One of the major aspect is design, synthesis and investigation of mechanism of action, as well as physicochemical properties of designed biologically active compounds.
the emergence of drug-resistant (DR) strains of Mycobac-terium tuberculosis effectively. According to the WHO 2018 report, not all DR-TB cases are diagnosed (only 51% of people with bacteriologically confirmed TB were tested for rifampicin resis-tance (RR) in 2018), and not all DR-TB cases were treated (onlyone in